蒙波克斯 (Mox Mpox) 是一个
Kaileen Jafari1, George A Woodward2
1From the Assistant Professor.
Pediatric emergency care
|October 30, 2023
概括
人类麻疹 (原名麻疹) 是一种罕见但正在出现的动物传播疾病. 儿科mopox病例并不常见,但医疗保健提供者应认识到其特征,以便及时诊断和护理.
科学领域:
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
- 儿科 儿科 儿科
背景情况:
- 人类mopox是一种致动物性病毒性疾病,引起类似天花的疾病.
- 1970年首次发现的mopox疫情在历史上局限于特有地区.
- 2022年全球暴增导致国际关注的公共卫生紧急情况宣言.
研究的目的:
- 通知儿科急诊和紧急护理提供者关于儿童和青少年的mpox.
- 突出儿童群体中mopox的临床特征,治疗和预防.
- 提高对mopox作为影响年轻人的新兴传染病的认识.
主要方法:
- 对mopox流行病学和临床数据的审查,重点关注儿科病例.
- 分析非流行国,特别是美国的病例分布.
- 综合有关传播,临床表现和管理策略的信息.
主要成果:
- 截至2022年9月,美国儿童和青少年的Mpox病例仅占总病例的0.3%.
- 大多数儿科感染是由于家庭与感染者直接接触造成的.
- 全球和美国大多数mopox病例发生在成年人身上,特别是与男性发生性关系的男性.
结论:
- 虽然不常见,但mopox对儿童和青少年构成风险.
- 儿童医疗保健提供者需要为潜在的mopox病例做好准备.
- 了解mopox的临床特征,治疗和预防对于有效的儿科护理至关重要.
更多相关视频
06:57Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
2.3K
10:16Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
3.3K
相关概念视频
Methods of Documentation II: POMR
966
The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
966
Olefin Metathesis Polymerization: Ring-Opening Metathesis Polymerization (ROMP)
2.6K
Ring-opening metathesis polymerization or ROMP involves strained cycloalkenes as starting materials. The mechanism of ROMP proceeds by reacting cycloalkene with Grubbs catalyst to give metallacyclobutane intermediate which undergoes a ring-opening reaction to form new carbene. The new carbene reacts with another molecule of cycloalkene. Repetition of these steps leads to the formation of an unsaturated open-chain polymer product. All these steps are reversible, however, relieving the ring...
2.6K
Pneumothorax-II
170
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
170
Pneumothorax-I
225
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
225
Protein Import into the Peroxisomes
3.5K
Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
3.5K
Pneumonia IV: Management
338
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
338
